Dietary vaccenic acid has antiatherogenic effects in LDLr-/- mice

Journal of Nutrition

Volumn 140, Issue 1, 2010, Pages 18-24

  Bassett, Chantal M C ^a   Edel, Andrea L ^a   Patenaude, Amanda F ^a   McCullough, Richelle S ^a   Blackwood, David P ^a   Chouinard, P Yvan ^b   Paquin, Paul ^b   Lamarche, Benoît ^b   Pierce, Grant N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ELAIDIC ACID; HYDROGENATED VEGETABLE OIL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRANS FATTY ACID; TRIACYLGLYCEROL; VACCENIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; ATHEROSCLEROTIC PLAQUE; BUTTER; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED STUDY; DAIRY PRODUCT; FAT CONTENT; FEMALE; MOUSE; NONHUMAN; PORK; SOYBEAN; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTILIPEMIC AGENTS; AORTA; CHOLESTEROL; DIET; DIETARY FATS; EATING; FEMALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLEIC ACIDS; RECEPTORS, LDL; TRIGLYCERIDES; WEIGHT GAIN;

ANIMALIA; MUS;

EID: 73649128861     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.109.105163     Document Type: Article

References (41)

1. Mendis S, Abegunde D, Yusuf S, Ebrahim S, Shaper G, Ghannem H, Shengelia B. WHO study on Prevention of Recurrences of Myocardial Infarction and Stroke (WHO-PREMISE). Bull World Health Organ. 2005;83:820-9.
2. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-52.
3. Iqbal R, Anand S, Ounpuu S, Islam S, Zhang X, Rangarajan S, Chifamba J, Al-Hinai A, Keltai M, et al. Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART study. Circulation. 2008;118:1929-37.
4. Ghahremanpour F, Firoozrai M, Darabi M, Zavarei A, Mohebbi A. Adipose tissue trans fatty acids and risk of coronary artery disease: a case-control study. Ann Nutr Metab. 2008;52:24-8.
5. Lemaitre RN, King IB, Raghunathan TE, Pearce RM, Weinmann S, Knopp RH, Copass MK, Cobb LA, Siscovick DS. Cell membrane transfatty acids and the risk of primary cardiac arrest. Circulation. 2002;105: 697-701.
6. Mozaffarian D, Rimm EB, King IB, Lawler RL, McDonald GB, Levy WC. Trans fatty acids and systemic inflammation in heart failure. Am J Clin Nutr. 2004;80:1521-5.
7. Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, Willett WC, Hu FB. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr. 2005;135:562-6.
8. Sundram K, French MA, Clandinin MT. Exchanging partially hydrogenated fat for palmitic acid in the diet increases LDL-cholesterol and endogenous cholesterol synthesis in normocholesterolemic women. Eur J Nutr. 2003;42:188-94.
9. Niu SL, Mitchell DC, Litman BJ. Trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cis analogs. Biochemistry. 2005;44:4458-65.
10. Cassagno N, Palos-Pinto A, Costet P, Breilh D, Darmon M, Berard AM. Low amounts of trans 18:1 fatty acids elevate plasma triacylglycerols but not cholesterol and alter the cellular defence to oxidative stress in mice. Br J Nutr. 2005;94:346-52.
11. Ibrahim A, Natrajan S, Ghafoorunissa R. Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats. Metabolism. 2005;54:240-6.
12. Gebauer SK, Psota TL, Kris-Etherton PM. The diversity of health effects of individual trans fatty acid isomers. Lipids. 2007;42:787-99.
13. Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser. 2003;916:i-viii, 1-149.
14. Leth T, Jensen HG, Mikkelsen AA, Bysted A. The effect of the regulation on trans fatty acid content in Danish food. Atheroscler Suppl. 2006;7:53-6.
15. Health Canada. TRANSforming the food supply: report of the Trans Fat Task Force. Ottawa: 2006. Available from: http://www.hc-sc.gc.ca/fn-an/nutrition/ gras-trans-fats/tf-gt-rep-rap-eng.php.
16. New York City Department of Health and Mental Hygiene. Notice of the adoption of an amendment (81.08) to Article 81 of the New York City Health Code. New York City; 2006.
17. Bortolotto JW, Reis C, Ferreira A, Costa S, Mottin CC, Souto AA, Guaragna RM. Higher content of trans fatty acids in abdominal visceral fat of morbidly obese individuals undergoing bariatric surgery compared to non-obese subjects. Obes Surg. 2005;15:1265-70.
18. Stachowska E, Dolegowska B, Chlubek D, Wesolowska T, Ciechanowski K, Gutowski P, Szumilowicz H, Turowski R. Dietary trans fatty acids and composition of human atheromatous plaques. Eur J Nutr. 2004;43:313-8.
19. Breslow JL. Mouse models of atherosclerosis. Science. 1996;272:685-8.
20. Ameredes BT, Watchko JF, Daood MJ, Rosas JF, Donahoe MP, Rogers RM. Growth hormone improves body mass recovery with refeeding after chronic undernutrition-induced muscle atrophy in aging male rats. J Nutr. 1999;129:2264-70.
21. Olfert ED, Cross BM, McWilliam AA, eds. Canadian Council on Animal Care guide to the care and use of experimental animals. 1st vol, 2nd ed. Ottawa: Bradda Printing Services Inc.; 1993.
22. Motard-Belanger A, Charest A, Grenier G, Paquin P, Chouinard Y, Lemieux S, Couture P, Lamarche B. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr. 2008;87:593-9.
23. Dupasquier CM, Dibrov E, Kneesh AL, Cheung PK, Lee KG, Alexander HK, Yeganeh BK, Moghadasian MH, Pierce GN. Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. Am J Physiol Heart Circ Physiol. 2007;293:H2394-402.
24. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497-509.
25. Park PW, Goins RE. In situ preparation of fatty acid methyl esters for analysis of fatty acid composition in foods. J Food Sci. 1994;59:1262-6.
26. Cruz-Hernandez C, Deng Z, Zhou J, Hill AR, Yurawecz MP, Delmonte P, Mossoba MM, Dugan ME, Kramer JK. Methods for analysis of conjugated linoleic acids and trans-18:1 isomers in dairy fats by using a combination of gas chromatography, silver-ion thin-layer chromatography/gas chromatography, and silver-ion liquid chromatography. J AOAC Int. 2004;87:545-62.
27. Kramer JK, Hernandez M, Cruz-Hernandez C, Kraft J, Dugan ME. Combining results of two GC separations partly achieves determination of all cis and trans 16:1, 18:1, 18:2 and 18:3 except CLA isomers of milk fat as demonstrated using Ag-ion SPE fractionation. Lipids. 2008;43:259-73.
28. FDA. Food labeling: trans fatty acids in nutrition labeling, nutrient content claims, and health claims. Final rule. Fed Regist. 2003;68: 41433-506.
29. Rudel LL, Kelley K, Sawyer JK, Shah R, Wilson MD. Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human ApoB100-overexpressing transgenic mice. Arterioscler Thromb Vasc Biol. 1998;18:1818-27.
30. Jakobsen MU, Overvad K, Dyerberg J, Heitmann BL. Intake of ruminant trans fatty acids and risk of coronary heart disease. Int J Epidemiol. 2008;37:173-82.
31. Chardigny JM, Destaillats F, Malpuech-Brugere C, Moulin J, Bauman DE, Lock AL, Barbano DM, Mensink RP, Bezelgues JB, et al. Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr. 2008;87:558-66.
32. Tholstrup T, Raff M, Basu S, Nonboe P, Sejrsen K, Straarup EM. Effects of butter high in ruminant trans and monounsaturated fatty acids on lipoproteins, incorporation of fatty acids into lipid classes, plasma C-reactive protein, oxidative stress, hemostatic variables, and insulin in healthy young men. Am J Clin Nutr. 2006;83:237-43.
33. Raff M, Tholstrup T, Sejrsen K, Straarup EM, Wiinberg N. Diets rich in conjugated linoleic acid and vaccenic acid have no effect on blood pressure and isobaric arterial elasticity in healthy young men. J Nutr. 2006;136:992-7.
34. Meijer GW, van Tol A, van Berkel TJ, Weststrate JA. Effect of dietary elaidic versus vaccenic acid on blood and liver lipids in the hamster. Atherosclerosis. 2001;157:31-40.
35. Lock AL, Horne CA, Bauman DE, Salter AM. Butter naturally enriched in conjugated linoleic acid and vaccenic acid alters tissue fatty acids and improves the plasma lipoprotein profile in cholesterol-fed hamsters. J Nutr. 2005;135:1934-9.
36. Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke. 2006;37:1923-32.
37. Han SN, Leka LS, Lichtenstein AH, Ausman LM, Schaefer EJ, Meydani SN. Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res. 2002;43: 445-52.
38. Mozaffarian D. Trans fatty acids - effects on systemic inflammation and endothelial function. Atheroscler Suppl. 2006;7:29-32.
39. Lee Y, Thompson JT, de Lera AR, Vanden Heuvel JP. Isomer-specific effects of conjugated linoleic acid on gene expression in RAW 264.7. J Nutr Biochem. 2009;20:848-59.
40. Goel DP, Maddaford TG, Pierce GN. Effects of omega-3 polyunsaturated fatty acids on cardiac sarcolemmal Na(+)/H(+) exchange. Am J Physiol Heart Circ Physiol. 2002;283:H1688-94.
41. Ander BP, Hurtado C, Raposo CS, Maddaford TG, Deniset JF, Hryshko LV, Pierce GN, Lukas A. Differential sensitivities of the NCX1.1 and NCX1.3 isoforms of the Na+-Ca2+ exchanger to alpha-linolenic acid. Cardiovasc Res. 2007;73:395-403.